Market overview

Market Overview — October 26, 2026

Price action matches a rebound narrative. After a down week capped by Friday's sharp Dow selloff, U.S. stock markets closed lower on Friday as investors worried about soaring crude oil prices, compounded by a weak economic data print, which pushed the CBOE Volatility Index (VIX) up 2.2% to 19.45. Monday brought relief: stocks rose in early trading as investors looked to rebound from last week's losses ahead of a week packed with major earnings reports and a Federal Reserve meeting, and the VIX fell back to roughly 18.5 (down ~4.7% on the day) — consistent with the session-level bounce seen in the SPY/QQQ/DIA levels above, though it doesn't erase the risk-reduction visible in this period's equal-weight and biotech relative-strength readings.

Main catalysts: (1) Oil retreat — a drop in oil prices gave the rest of the market some breathing room after last week's losses, reversing a key source of Friday's inflation anxiety. (2) AI/mega-cap news — Anthropic's IPO filing put AI back in the spotlight and pushed chip stocks up, which is the main driver of Monday's Nasdaq-led bounce (note: this intraday tech pop doesn't reverse the one-month trend in the data above, where QQQ still trails SPY by ~3.6 points over the month — tech has been the weaker group on a trailing-month basis even as it led today). (3) Fed meeting ahead — the Federal Reserve will announce its next decision on Wednesday 28 October 2026, having raised rates 25 basis points on 16 September, its first hike since July 2023, and markets are now pricing a roughly 93-94% chance the Fed holds rates steady at 3.75%–4.00% rather than hiking again, with December seen as the more likely window for any further move. September PCE inflation data, due October 29, adds to the event risk this week, alongside midterm-election positioning.

Sector/stock notes (informational, not recommendations): Friday's weakness was broad — consumer staples fell while energy was the standout gainer on the oil spike; Monday's recovery saw chip/AI names and Tesla outperform, while a couple of single names (Fair Isaac, Moderna) saw outsized declines on company-specific news. Taken together, the tape reflects a market in a holding pattern — a short-term bounce on falling oil and AI-IPO optimism, set against a month-long backdrop of reduced speculative risk appetite (biotech underperforming) and a Nasdaq/tech complex that has lagged the broader, more equal-weighted market, all ahead of Wednesday's pivotal Fed decision.